The Latest Breaking News from Glaxo

Selling cash secured puts on stocks an investor is happy to take ownership of is a great way to generate some extra income.

Income investors tend to gravitate towards covered calls, and blue-chip high yielding stocks are a great place to start.

U.S. regulators say GlaxoSmithKline’s COVID-19 antibody drug should no longer be used because it is likely ineffective against the latest version of the virus that accounts for most cases

According to a British study, Eli Lilly And Co (NYSE:LLY) and Incyte Corporation's (NASDAQ:INCY) Olumiant (baricitinib) reduced the risk of death in hospitalized COVID-19 patients by 13%. According to a Reuters report, more than 8,000 patients were administered baricitinib in addition to standard of care in the RECOVERY Trial. Results showed that 546 patients…

GlaxoSmithKline Plc (NYSE: GSK) has halte

THE new consumer healthcare company to be spun out from GlaxoSmithKline will be named Haleon,  it was announced today.

GlaxoSmithKline remained under pressure today after so-so results that drew unfavourable comparisons with US rival Pfizer.

GlaxoSmithKline boss Dame Emma Walmsley today promised a “step-change in growth” during a landmark year for the pharma giant.

Drugmaker GlaxoSmithKline today claimed a landmark victory in its competitive battle to dominate HIV treatment as a US rival agreed to hand over $1.25 billion to end a high-stakes global patent dispute.